Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors

作者：Gomes Debora C; Valadares Ana L R; de Moraes Monica J; Lagrutta Bianca B; Pinto Neto Aarao M; Costa Paiva Lucia^*

来源：Menopause-The Journal of the North American Menopause Society, 2015, 22(2): 224-230.

DOI：10.1097/gme.0000000000000282

• Acquired immune deficiency syndrome
• Human immunodeficiency virus
• Bone mineral density
• Menopause
• Aging

Objective: Low bone mineral density (BMD) has been found in human immunodeficiency virus (HIV)-infected patients; however, data on associated factors remain unclear, specifically in middle-aged women. This study aims to evaluate factors associated with low BMD in HIV-positive women.
Methods: In this cross-sectional study, a questionnaire was administered to 206 HIV-positive women aged 40 to 60 years who were receiving outpatient care. Clinical features, laboratory test results, and BMD were assessed. Yates and Pearson chi(2) tests and Poisson multiple regression analysis were performed.
Results: The median age of women was 47.7 years; 75% had nadir CD4 T-cell counts higher than 200, and 77.8% had viral loads below the detection limit. There was no association between low BMD at the proximal femur and lumbar spine (L1-L4) and risk factors associated with HIV infection and highly active antiretroviral therapy. Poisson multiple regression analysis showed that the only factor associated with low BMD at the proximal femur and lumbar spine was postmenopause status.
Conclusions: Low BMD is present in more than one third of this population sample, in which most women are using highly active antiretroviral therapy and have a well-controlled disease. The main associated factor is related to estrogen deprivation. The present data support periodic BMD assessments in HIV-infected patients and highlight the need to implement comprehensive menopausal care for these women to prevent bone loss.

• 出版日期2015-2